<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Law Times Journal</provider_name><provider_url>https://lawtimesjournal.in</provider_url><author_name>Shubhi Shukla</author_name><author_url>https://lawtimesjournal.in/author/shubhi-shukla/</author_url><title>Regulate black marketing of COVID 19 medicines: Appeal filed before Delhi HC - Law Times Journal</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="7hzAJV9Sn3"&gt;&lt;a href="https://lawtimesjournal.in/regulate-black-marketing-of-covid-19-medicines-appeal-filed-before-delhi-hc/"&gt;Regulate black marketing of COVID 19 medicines: Appeal filed before Delhi HC&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://lawtimesjournal.in/regulate-black-marketing-of-covid-19-medicines-appeal-filed-before-delhi-hc/embed/#?secret=7hzAJV9Sn3" width="600" height="338" title="&#x201C;Regulate black marketing of COVID 19 medicines: Appeal filed before Delhi HC&#x201D; &#x2014; Law Times Journal" data-secret="7hzAJV9Sn3" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]&gt; */
&lt;/script&gt;
</html><thumbnail_url>https://lawtimesjournal.in/wp-content/uploads/2021/04/download-10.jpeg</thumbnail_url><thumbnail_width>311</thumbnail_width><thumbnail_height>162</thumbnail_height><description>On Monday, an appeal has been filed before the Delhi High Court asking for directions to regulate black marketing of COVID 19 medicines and to make sure theory availability and acquirement in a time-bound and see-through manner. The appeal comprised the severe shortage of medicines used for curing COVID patients such as Remdesivir, Favipiravir, Fabiflu, Tocilizumab, etc. in the capital and the absence of any see-through and time-bound mechanism to acquire the same. The petitioner stated that it was due to the non-availability of the above-prescribed medicines with the hospital and chemists or even the Office of the Drug Controller that her father gave away to COVID 19.</description></oembed>
